Nabriva Therapeutics SEC Filings https://investors.nabriva.com/ Nabriva Therapeutics SEC Filings en DEF 14A: Official notification to shareholders of matters to be brought to a vote ("Proxy") https://investors.nabriva.com/sec-filings/sec-filing/def-14a/0001047469-19-003649 Nabriva Therapeutics plc Fri, 14 Jun 2019 16:26:38 -0400 Nabriva Therapeutics SEC Filings 8951 10-Q: Quarterly report which provides a continuing view of a company's financial position https://investors.nabriva.com/sec-filings/sec-filing/10-q/0001104659-19-028565 Nabriva Therapeutics plc Fri, 10 May 2019 14:33:36 -0400 Nabriva Therapeutics SEC Filings 8896 8-K: Report of unscheduled material events or corporate event https://investors.nabriva.com/sec-filings/sec-filing/8-k/0001104659-19-028448 Nabriva Therapeutics plc Fri, 10 May 2019 08:32:23 -0400 Nabriva Therapeutics SEC Filings 8886 8-K: Report of unscheduled material events or corporate event https://investors.nabriva.com/sec-filings/sec-filing/8-k/0001104659-19-025701 Nabriva Therapeutics plc Wed, 01 May 2019 07:34:59 -0400 Nabriva Therapeutics SEC Filings 8841 8-K: Report of unscheduled material events or corporate event https://investors.nabriva.com/sec-filings/sec-filing/8-k/0001104659-19-018855 Nabriva Therapeutics plc Mon, 01 Apr 2019 08:37:46 -0400 Nabriva Therapeutics SEC Filings 8806 CT ORDER: CT ORDER https://investors.nabriva.com/sec-filings/sec-filing/ct-order/9999999997-19-001943 Nabriva Therapeutics plc Mon, 25 Mar 2019 17:30:01 -0400 Nabriva Therapeutics SEC Filings 8796 S-8: Securities offered to employees pursuant to employee benefit plans https://investors.nabriva.com/sec-filings/sec-filing/s-8/0001104659-19-014287 Nabriva Therapeutics plc Tue, 12 Mar 2019 21:04:24 -0400 Nabriva Therapeutics SEC Filings 8786 10-K: Annual report which provides a comprehensive overview of the company for the past year https://investors.nabriva.com/sec-filings/sec-filing/10-k/0001047469-19-001138 Nabriva Therapeutics plc Tue, 12 Mar 2019 16:42:17 -0400 Nabriva Therapeutics SEC Filings 8781 8-K: Report of unscheduled material events or corporate event https://investors.nabriva.com/sec-filings/sec-filing/8-k/0001104659-19-014080 Nabriva Therapeutics plc Tue, 12 Mar 2019 07:33:50 -0400 Nabriva Therapeutics SEC Filings 8776 8-K: Report of unscheduled material events or corporate event https://investors.nabriva.com/sec-filings/sec-filing/8-k/0001104659-19-009191 Nabriva Therapeutics plc Tue, 19 Feb 2019 08:04:38 -0500 Nabriva Therapeutics SEC Filings 8766